Published in Br J Dermatol on August 01, 2006
Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses. Clin Cosmet Investig Dermatol (2011) 0.81
Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials. World J Biol Chem (2016) 0.79
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. Exp Dermatol (2014) 0.75
[Anal HPV infections]. Wien Klin Wochenschr (2008) 0.75
Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science (1992) 6.72
Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr Biol (1998) 5.94
Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction. J Clin Microbiol (1989) 4.46
Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell (2000) 4.45
Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell (1998) 3.90
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res (1996) 3.77
Physical activity in patients with COPD. Eur Respir J (2008) 3.75
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Interleukin-10 therapy--review of a new approach. Pharmacol Rev (2003) 3.51
Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun (1992) 3.47
Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science (1999) 3.42
Spatial sensing in fibroblasts mediated by 3' phosphoinositides. J Cell Biol (2000) 3.21
Spatial dynamics of GFP-tagged proteins investigated by local fluorescence enhancement. Nat Biotechnol (1996) 3.19
Efficient chromosome capture requires a bias in the 'search-and-capture' process during mitotic-spindle assembly. Curr Biol (2005) 3.08
Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron (1994) 3.00
Compartmentalized IgE receptor-mediated signal transduction in living cells. J Cell Biol (1997) 2.91
Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron (2001) 2.71
Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. J Cell Biol (1998) 2.65
Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli. J Clin Microbiol (1989) 2.62
Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28
Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J Cell Biol (2001) 2.28
Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell (2000) 2.27
Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain. Proc Natl Acad Sci U S A (2000) 2.20
Subcellular targeting by membrane lipids. Curr Opin Cell Biol (2001) 2.18
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology (2004) 2.14
CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/beta heterooligomers to dendritic spines. Neuron (1998) 2.13
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Calcium-induced restructuring of nuclear envelope and endoplasmic reticulum calcium stores. Cell (1997) 1.96
Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate. Mol Pharmacol (1997) 1.96
Retracted Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci U S A (1995) 1.93
Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol (2007) 1.89
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry (1998) 1.86
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun (2009) 1.81
A versatile microporation technique for the transfection of cultured CNS neurons. J Neurosci Methods (1999) 1.80
Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol (2000) 1.76
Molecular memory by reversible translocation of calcium/calmodulin-dependent protein kinase II. Nat Neurosci (2000) 1.74
ACTN3 genotype in professional soccer players. Br J Sports Med (2007) 1.71
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur J Biochem (1995) 1.69
Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol (1989) 1.68
Elementary calcium-release units induced by inositol trisphosphate. Science (1997) 1.67
Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol (1999) 1.67
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
PKC412--a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des (2000) 1.63
Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer (2000) 1.60
Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase-mRNA. Eur J Cancer (1996) 1.59
Organization of the monocyte/macrophage system of normal human skin. J Invest Dermatol (1990) 1.58
Electroporation-induced formation of individual calcium entry sites in the cell body and processes of adherent cells. Biophys J (1997) 1.58
Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome. Arthritis Rheum (1999) 1.56
Is there an interaction between interleukin-10 and interleukin-22? Genes Immun (2005) 1.54
Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement. Br J Dermatol (2004) 1.53
Combined action of mouse alpha and beta interferons in influenza virus-infected macrophages carrying the resistance gene Mx. J Virol (1984) 1.52
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis (2005) 1.47
Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy. Br J Dermatol (1998) 1.47
Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood (1999) 1.47
Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A (1999) 1.46
Identification of common dermatophytes (Trichophyton, Microsporum, Epidermophyton) using polymerase chain reactions. Br J Dermatol (1998) 1.44
T-cell receptor and immunoglobulin gene rearrangements in cutaneous T-cell-rich pseudolymphomas. J Invest Dermatol (1990) 1.43
[Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia]. Dtsch Med Wochenschr (1997) 1.42
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol (2007) 1.42
Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. J Natl Cancer Inst (1974) 1.42
Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol (2015) 1.41
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest (1998) 1.40
Verrucosis of hands and feet in a patient with combined immune deficiency. J Am Acad Dermatol (1997) 1.39
Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun (1998) 1.38
Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. Cell Growth Differ (1994) 1.37
Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant (2008) 1.35
Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol (2001) 1.35
Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer (2002) 1.32
Reversible desensitization of inositol trisphosphate-induced calcium release provides a mechanism for repetitive calcium spikes. J Biol Chem (1996) 1.29
Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol (2009) 1.28
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol (2007) 1.28
Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol (2007) 1.26
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol (1999) 1.26
Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome? Ann Oncol (2005) 1.25
Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol (1993) 1.24
Coordinated oscillations in cortical actin and Ca2+ correlate with cycles of vesicle secretion. Nat Cell Biol (2012) 1.23
A continuous T-cell line from a patient with Sézary syndrome. Arch Dermatol Res (1987) 1.23
Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol (2007) 1.21
Control of astrocyte Ca(2+) oscillations and waves by oscillating translocation and activation of protein kinase C. Curr Biol (2001) 1.20
Sclerotherapy for treatment of hemangiomas. Dermatol Surg (2000) 1.19
Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis (1998) 1.19
Source of nuclear calcium signals. Proc Natl Acad Sci U S A (1994) 1.17
Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett (1994) 1.16
Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care (2010) 1.16
Localized calcium spikes and propagating calcium waves. Cell Calcium (1993) 1.16
Lymphogranuloma venereum emerging in men who have sex with men in Germany. Euro Surveill (2006) 1.15
Prenylation-dependent association of Ki-Ras with microtubules. Evidence for a role in subcellular trafficking. J Biol Chem (1997) 1.14
Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses (2001) 1.14
Glomerular permeability barrier in the rat. Functional assessment by in vitro methods. J Clin Invest (1993) 1.14
The natural history of actinic keratosis: a systematic review. Br J Dermatol (2013) 1.14